{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:15:21Z","timestamp":1786947321997,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.forsciint.2025.112437","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T23:32:16Z","timestamp":1743377536000},"page":"112437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Inhalation and oral administration of HHC products \u2013 Quantification of (9R)-, (9S)-Hexahydrocannabinol and metabolites in plasma and detectability in on-site drug tests for urine and oral fluid"],"prefix":"10.1016","volume":"370","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9084-9635","authenticated-orcid":false,"given":"L.","family":"Lucuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Liut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nauroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Juebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Andresen-Streichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.forsciint.2025.112437_bib1","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/ja01866a040","article-title":"Structure of cannabidiol. VI. Isomerization of cannabidiol to tetrahydrocannabinol, a physiologically active product. Conversion of cannabidiol to cannabinol1","volume":"62","author":"Adams","year":"1940","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.forsciint.2025.112437_bib2","article-title":"Hexahydrocannabinol (HHC) and related substances","author":"European Union Drug Agency","year":"2023","journal-title":"Eur. Monit. Cent. Drugs Drug Addict."},{"issue":"1","key":"10.1016\/j.forsciint.2025.112437_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38188-5","article-title":"Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC)","volume":"13","author":"Russo","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.forsciint.2025.112437_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/jps.2600680319","article-title":"Structure-activity studies on tetrahydro-and hexahydrocannabinol derivatives","volume":"68","author":"Skinner","year":"1979","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.forsciint.2025.112437_bib5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1021\/jm00376a029","article-title":"Activity of novel aminocannabinoids in baboons","volume":"27","author":"Edery","year":"1984","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.forsciint.2025.112437_bib6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/metabo13121169","article-title":"Evidence of 11-hydroxy-hexahydrocannabinol and 11-nor-9-carboxy-hexahydrocannabinol as novel human metabolites of \u03949-tetrahydrocannabinol","volume":"13","author":"Falck J\u00f8rgensen","year":"2023","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.forsciint.2025.112437_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0091-3057(91)90359-A","article-title":"Comparative in vitro metabolism of the cannabinoids","volume":"40","author":"Harvey","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.forsciint.2025.112437_bib8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/jm00127a038","article-title":"The importance of the orientation of the C9 substituent to cannabinoid activity","volume":"32","author":"Reggio","year":"1989","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.forsciint.2025.112437_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.1971.tb13985.x","article-title":"Structural requirements for cannabinoid activity","volume":"191","author":"Edery","year":"1971","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.forsciint.2025.112437_bib10","first-page":"bkad079","article-title":"Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC\u2013HRMS-MS","author":"Manier","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112437_bib11","article-title":"Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples","author":"Lindbom","year":"2024","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2025.112437_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/14690667231200139","article-title":"Identification of human hexahydrocannabinol metabolites in urine","author":"Schirmer","year":"2023","journal-title":"Eur. J. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2025.112437_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115918","article-title":"The first LC-MS\/MS stereoselective bioanalytical methods to quantitatively detect 9R-and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine","volume":"240","author":"Kobidze","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.forsciint.2025.112437_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/ph17020249","article-title":"Disposition of hexahydrocannabinol epimers and their metabolites in biological matrices following a single administration of smoked hexahydrocannabinol: a preliminary study","volume":"17","author":"Di Trana","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.forsciint.2025.112437_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jat\/bkae022","article-title":"Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography\u2013high-resolution tandem mass spectrometry","volume":"48","author":"Pitterl","year":"2024","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112437_bib16","article-title":"A survey study of individuals using hexahydrocannabinol cannabis products: use patterns and perceived effects","author":"Ferretti","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.forsciint.2025.112437_bib17","article-title":"Quantification of (9R)-and (9S)-hexahydrocannabinol (HHC) via GC\u2013MS in serum\/plasma samples from drivers suspected of cannabis consumption and immunological detection of HHC and related substances in serum, urine, and saliva","author":"Hoefert","year":"2023","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.forsciint.2025.112437_bib18","first-page":"142","article-title":"Richtlinie der GTFCh zur Qualit\u00e4tssicherung bei forensisch-toxikologischen Untersuchungen","volume":"76","author":"Paul","year":"2009","journal-title":"Toxichem Krimtech"},{"key":"10.1016\/j.forsciint.2025.112437_bib19","unstructured":"F. Peters, O. Drummer, F. Musshoff, Anhang B zur Richtlinie der GTFCh zur Qualit\u00e4tssicherung bei forensich-toxikologischen Untersuchungen: Anforderung an die Validierung von Analysensystemen, 2012."},{"issue":"6","key":"10.1016\/j.forsciint.2025.112437_bib20","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1111\/1556-4029.13168","article-title":"A 2-year study of \u03b4 9-tetrahydrocannabinol concentrations in drivers: examining driving and field sobriety test performance","volume":"61","author":"Declues","year":"2016","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2025.112437_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.aap.2015.10.019","article-title":"The standardized field sobriety tests (SFST) and measures of cognitive functioning","volume":"86","author":"Downey","year":"2016","journal-title":"Accid. Anal. Prev."},{"key":"10.1016\/j.forsciint.2025.112437_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.aap.2016.04.012","article-title":"Drug recognition expert (DRE) examination characteristics of cannabis impairment","volume":"92","author":"Hartman","year":"2016","journal-title":"Accid. Anal. Prev."},{"issue":"9","key":"10.1016\/j.forsciint.2025.112437_bib23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jamapsychiatry.2023.2345","article-title":"Evaluation of field sobriety tests for identifying drivers under the influence of cannabis: a randomized clinical trial","volume":"80","author":"Marcotte","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.forsciint.2025.112437_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/9781118570654.ch49","article-title":"Issues affecting interpretation: stability and artefacts","author":"Skopp","year":"2014","journal-title":"Handb. Forensic Med."},{"key":"10.1016\/j.forsciint.2025.112437_bib25","first-page":"bkae030","article-title":"Quantitation of hexahydrocannabinol (HHC) and metabolites in blood from DUID-cases","author":"Kronstrand","year":"2024","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.forsciint.2025.112437_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9711","article-title":"Identification and quantification of both isomers of hexahydrocannabinol,(9 R)-hexahydrocannabinol and (9 S)-hexahydrocannabinol, in three different matrices by mass spectrometry","volume":"38","author":"Bottinelli","year":"2024","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"8","key":"10.1016\/j.forsciint.2025.112437_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/ph14080817","article-title":"Pharmacokinetic investigation of commercially available edible marijuana products in humans: potential influence of body composition and influence on glucose control","volume":"14","author":"Ewell","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.forsciint.2025.112437_bib28","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1373\/clinchem.2016.263475","article-title":"Free and glucuronide whole blood cannabinoids' pharmacokinetics after controlled smoked, vaporized, and oral cannabis administration in frequent and occasional cannabis users: identification of recent cannabis intake","volume":"62","author":"Newmeyer","year":"2016","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.forsciint.2025.112437_bib29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112437_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107969","article-title":"Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis","volume":"211","author":"Schlienz","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.forsciint.2025.112437_bib31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/02698811211021583","article-title":"Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis","volume":"35","author":"Spindle","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.forsciint.2025.112437_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jat\/bkv012","article-title":"Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers","volume":"39","author":"Desrosiers","year":"2015","journal-title":"J. Anal. Toxicol."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T22:53:35Z","timestamp":1745880815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073825000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"alternative-id":["S0379073825000751"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112437","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalation and oral administration of HHC products \u2013 Quantification of (9R)-, (9S)-Hexahydrocannabinol and metabolites in plasma and detectability in on-site drug tests for urine and oral fluid","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112437"}}